{
  "patent_number": "US 12564648",
  "country": "US",
  "title": "Gene Editing T-Cells to Fight CD7 Blood Cancers",
  "original_title": "Gene editing of CAR-T cells for the treatment of T cell malignancies with chimeric antigen receptors",
  "summary": "This patent describes a method to treat specific blood cancers by using genetically modified T-cells that are engineered to attack cancer cells without harming themselves or triggering severe immune reactions in the patient.",
  "what_it_does": "This patent outlines a method for treating CD7 positive hematologic cancers, which are types of blood cancer, in humans. It involves administering specially modified human T cells. These T cells are engineered to express a Chimeric Antigen Receptor (CAR) that specifically binds to a protein called CD7, which is found on the cancer cells (Claim 1a). Crucially, these T cells have two genetic modifications: a first 'indel' (a small insertion or deletion) in their own CD7 gene, making them 'CD7 deficient' (Claim 1b), and a second indel in their T cell Receptor Alpha Chain (TRAC) gene, making them 'TRAC deficient' (Claim 1c). The CD7 modification prevents the CAR-T cells from attacking each other (a problem called fratricide, Claim 7), while the TRAC modification helps prevent the modified cells from attacking the patient's healthy tissues (called alloreactivity or Graft-versus-Host Disease, Claim 10). For example, this method could be used to treat T-cell acute lymphoblastic leukemia (T-ALL) by infusing these specially prepared T cells into a patient (Claim 11, 12).",
  "what_it_does_not_cover": [
    "Does not cover CAR-T cells that target antigens other than CD7 (e.g., CD19 or BCMA).",
    "Does not cover CAR-T cells that lack a specific genetic modification (indel) in their own CD7 gene.",
    "Does not cover CAR-T cells that lack a specific genetic modification (indel) in their T cell Receptor Alpha Chain (TRAC) gene.",
    "Does not cover CAR-T cells where the genetic modifications are not 'indels' (e.g., gene insertions or point mutations).",
    "Does not cover methods for treating cancers that are not CD7 positive hematologic cancers.",
    "Does not cover CAR-T cells modified to prevent fratricide or alloreactivity through non-genetic means or different genetic targets."
  ],
  "filed": "2025-04-24",
  "granted": "2026-03-03",
  "expires": "2045-04-24",
  "status": "active",
  "holder": "Washington University in St. Louis",
  "holder_url": "https://patentbrief.org/company/washington-university-in-st-louis",
  "inventors": [
    {
      "name": "Matthew Cooper",
      "url": "https://patentbrief.org/inventor/matthew-cooper"
    },
    {
      "name": "John F. DiPersio",
      "url": "https://patentbrief.org/inventor/john-f-dipersio"
    }
  ],
  "times_cited": 0,
  "tags": [
    "biotech",
    "pharmaceutical",
    "gene_editing",
    "oncology"
  ],
  "abstract": "The present disclosure provides the use of fratricide-resistant chimeric antigen receptor T (CAR-T) cells targeting antigens expressed by T cell malignancies.",
  "url": "https://patentbrief.org/patent/us/12564648/gene-editing-of-car-t-cells-for-the-treatment-of-t-cell-malignancies-with-chimer",
  "markdown_url": "https://patentbrief.org/patent/us/12564648/gene-editing-of-car-t-cells-for-the-treatment-of-t-cell-malignancies-with-chimer/md",
  "google_patents_url": "https://patents.google.com/patent/US12564648",
  "relatedPatents": [
    {
      "patentNumber": "9328156",
      "countryCode": "US",
      "title": "How Genetically Modified T-Cells Attack Cancer",
      "url": "https://patentbrief.org/patent/us/9328156/use-of-chimeric-antigen-receptor-modified-t-cells-to-treat-cancer"
    },
    {
      "patentNumber": "9481728",
      "countryCode": "US",
      "title": "How Genetically Modified T-Cells Fight CD19 Cancers",
      "url": "https://patentbrief.org/patent/us/9481728/compositions-and-methods-for-treatment-of-cancer"
    },
    {
      "patentNumber": "12630603",
      "countryCode": "US",
      "title": "Making Better CAR-T Cells to Fight Lymphoma",
      "url": "https://patentbrief.org/patent/us/12630603/chimeric-antigen-receptor-t-cell-therapy-12630603"
    },
    {
      "patentNumber": "12600775",
      "countryCode": "US",
      "title": "Treating a Specific Lymphoma with Modified T Cells",
      "url": "https://patentbrief.org/patent/us/12600775/chimeric-antigen-receptor-t-cell-therapy"
    },
    {
      "patentNumber": "20240165159",
      "countryCode": "US",
      "title": "Targeting Cancer with CAR T Cells Using a Chemical Tag",
      "url": "https://patentbrief.org/patent/us/20240165159/compositions-and-methods-for-car-t-cell-therapy"
    }
  ]
}